Monitoring of cell therapeutics in vivo is of major importance to estimate its efficacy. Here, we present a novel intracellular label for 19F magnetic resonance imaging (MRI)-based cell tracking, which allows for noninvasive, longitudinal cell tracking without the use of radioisotopes. A key advantage of 19F MRI is that it allows for absolute quantification of cell numbers directly from the MRI data. The 19F label was tested in primary human monocyte-derived dendritic cells. These cells took up label effectively, resulting in a labeling of 1.7 6 0.1 3 1013 19F atoms per cell, with a viability of 80 6 6%, without the need for electroporation or transfection agents. This results in a minimum detection sensitivity of about 2,000 cells/voxel at...
The success of cellular therapies will depend in part on accurate delivery of cells to target organs...
The success of cellular therapies will depend in part on accurate delivery of cells to target organs...
Contains fulltext : 48743.pdf (publisher's version ) (Closed access)The success of...
Monitoring of cell therapeutics in vivo is of major importance to estimate its efficacy. Here, we pr...
Contains fulltext : 97581.pdf (publisher's version ) (Closed access)Monitoring of ...
Item does not contain fulltextNoninvasive in vivo cell tracking is crucial to fully understand the f...
Contains fulltext : 89778.pdf (publisher's version ) (Closed access)Cellular thera...
BACKGROUND AIMS: Dendritic cells (DC) are increasingly being used as cellular vaccines to treat canc...
Continuous advancements in noninvasive imaging modalities such as magnetic resonance imaging (MRI) h...
Item does not contain fulltext(19)F MRI is emerging as a new imaging technique for cell tracking. It...
Tolerogenic dendritic cell (tolDC) therapies aim to restore self-tolerance in patients suffering fro...
Tolerogenic dendritic cell (tolDC) therapies aim to restore self-tolerance in patients suffering fro...
Success of immunotherapy with dendritic cells (DC) to treat cancer is highly dependent on their inte...
Success of immunotherapy with dendritic cells (DC) to treat cancer is highly dependent on their inte...
Item does not contain fulltextBACKGROUND AIMS: Dendritic cells (DC) are increasingly being used as c...
The success of cellular therapies will depend in part on accurate delivery of cells to target organs...
The success of cellular therapies will depend in part on accurate delivery of cells to target organs...
Contains fulltext : 48743.pdf (publisher's version ) (Closed access)The success of...
Monitoring of cell therapeutics in vivo is of major importance to estimate its efficacy. Here, we pr...
Contains fulltext : 97581.pdf (publisher's version ) (Closed access)Monitoring of ...
Item does not contain fulltextNoninvasive in vivo cell tracking is crucial to fully understand the f...
Contains fulltext : 89778.pdf (publisher's version ) (Closed access)Cellular thera...
BACKGROUND AIMS: Dendritic cells (DC) are increasingly being used as cellular vaccines to treat canc...
Continuous advancements in noninvasive imaging modalities such as magnetic resonance imaging (MRI) h...
Item does not contain fulltext(19)F MRI is emerging as a new imaging technique for cell tracking. It...
Tolerogenic dendritic cell (tolDC) therapies aim to restore self-tolerance in patients suffering fro...
Tolerogenic dendritic cell (tolDC) therapies aim to restore self-tolerance in patients suffering fro...
Success of immunotherapy with dendritic cells (DC) to treat cancer is highly dependent on their inte...
Success of immunotherapy with dendritic cells (DC) to treat cancer is highly dependent on their inte...
Item does not contain fulltextBACKGROUND AIMS: Dendritic cells (DC) are increasingly being used as c...
The success of cellular therapies will depend in part on accurate delivery of cells to target organs...
The success of cellular therapies will depend in part on accurate delivery of cells to target organs...
Contains fulltext : 48743.pdf (publisher's version ) (Closed access)The success of...